COMMUNIQUÉS West-GlobeNewswire

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)
14/12/2024
UNLOXCYT is the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: [...]
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
13/12/2024
NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, [...]
Nova Leap Health Corp. provides update on Special Meeting
13/12/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Edesa Biotech Reports Fiscal Year 2024 Results
13/12/2024
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported [...]
MEDIROM Healthcare Technology‘s Subsidiary, MEDIROM MOTHER Labs, Raises an Aggregate Total of JPY260.3 Million in its Series A Financing Round
13/12/2024
Pre-Money Valuation of JPY9 Billion is Approximately Multiples of Current Parent Company Market Capitalization. Strategic Investors Further Validation of Technology and Growth Potential. Further Commercialization with [...]
Outlook Therapeutics® Streamlines Operations
13/12/2024
Full NORSE EIGHT Data Readout Expected January 2025 ISELIN, N.J., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the [...]
CorVel Announces Three-For-One Forward Stock Split and Authorized Share Increase
13/12/2024
FORT WORTH, Texas, Dec. 13, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announces that its Board of Directors approved a three-for-one forward stock split of its common stock. The Board also approved a [...]
Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
13/12/2024
Carlsbad, CA, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for [...]
BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering
13/12/2024
PHILADELPHIA and VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/12/2024
MALVERN, Pa., Dec. 13, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
13/12/2024
Incumbent Board has Destroyed Stockholder Value and Imperiled AIM’s Future through Breaches of Fiduciary Duty and Bad Faith Actions Stock Price has Declined by More than 99%, Clinical Strategy has Failed and AIM is on [...]
Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million
13/12/2024
Palvella Therapeutics to debut on Nasdaq under the ticker symbol “PVLA” as a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a platform for treating serious, rare [...]
L’édition 2024 du congrès FAAM-EUROBAT s’achève sur des avancées révolutionnaires en matière de recherche sur les allergies alimentaires et l’anaphylaxie
13/12/2024
ATHÈNES, Grèce, 13 déc. 2024 (GLOBE NEWSWIRE) -- L’édition 2024 du congrès FAAM-EUROBAT , organisé du 21 au 23 novembre à l’InterContinental Athenaeum d’Athènes, a rassemblé 550 participants en provenance de plus de 25 [...]
CannExpo 2025: Igniting the Cannabis Lifestyle in Toronto
13/12/2024
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- via IBN -- Get ready to elevate your cannabis experience at CannExpo 2025, Toronto's Cannabis Lifestyle Show, blazing into the Queen Elizabeth Building at Exhibition Place on [...]
Protest as MPPs come to Stratford on pre-budget tour: Local citizens angry at Ford government for underfunding, privatizing & destroying our public health care plan to make their voices heard
13/12/2024
Attn: Assignment Editor STRATFORD, Ontario, Dec. 13, 2024 (GLOBE NEWSWIRE) -- As the government travels to Stratford to hold Pre-Budget Hearings, concerned citizens from Stratford and area will gather to send a message [...]
Scilex Holding Company Announces Closing of $17 Million Registered Direct Offering
13/12/2024
PALO ALTO, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing the [...]
Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
13/12/2024
Incumbent Board has Destroyed Stockholder Value and Imperiled AIM’s Future through Breaches of Fiduciary Duty and Bad Faith Actions Stock Price has Declined by More than 99%, Clinical Strategy has Failed and AIM is on [...]
Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)
13/12/2024
DALLAS, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView ® System, which received Breakthrough Device Designation from the U.S. FDA in [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
13/12/2024
COPENHAGEN, Denmark, December 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial [...]

Pages